Page 7 - Pharmaceutical

Amgen and Immatics to collaborate for cancer drug research

Immatics to receive $ 30 mn upfront & potentially over $ 1 bn in milestone payments & royalties

Ajanta Pharma receives US FDA approval for antidepressant drug duloxetine

The approved product is a generic version of Eli Lilly & Co's Cymbalta capsule

Granules India receives 11 observations from Portuguese drug regulator

Infarmed, Portugal, issued these observations for Granules India's Gagillapur facility

Aurobindo acquires Portugal's Generis Farmaceutica for € 135 mn

The deal will help Aurobindo to establish itself as one of the leading generics players in Europe

US District Court rules in favour of Amgen in Repatha patents cases

The court has prohibited Sanofi & Regeneron from infringing two patents that Amgen holds for Repatha

Natco receives US FDA approval for cancer drug bendamustine

The approved product is generic version of Treanda, which has annual sales of about $ 133 mn in US

Stent prices likely to be aligned with CGHS rates

Stent makers have been at loggerheads over differential pricing of drug-eluting stents

FIPB approves Sweden-based Recipharm's Kemwell acquisition

In April 2016, Recipharm agreed to buy Kemwell's pharma contract development and manufacturing biz

Natco launches hepatitis C drug Velpanat in Nepal

Velpanat, a sofosbuvir-velpatasvir fixed dose combination, is generic version of Gilead's Epclusa

Zydus Healthcare buys six brands from MSD

Acquired brands belong to men's health, women's health, cardiovascular & wound management segments

The year that was 2016: A mixed bag for Indian pharma

Wockhardt has been the worst-hit with three plants being banned from exporting to the US

Glenmark to enhance R&D activity and focus on specialty products for growth

The company is targeting 30 percent of total revenues from specialty and innovation segments over the next decade

Cipla receives US FDA's approval for generic Tricor tablet

Tricor (fenofibrate) tablet and generic equivalents had US sales of approximately $ 307 million for the 12 month period ending October 2016, according to IMS Health

Lonza buys gelatin capsules maker Capsugel from KKR for $ 5.5 billion

With 13 facilities, which include a hard capsule manufacturing facility in Delhi (India), Capsugel is one of the leading global players in advanced oral dosage delivery technologies

Cipla to set up manufacturing facility for pharmaceuticals in Iran

For this, the company has agreed to form a joint venture with Iran's Ahran Tejarat Company with an investment of approximately Euro 16.875 million (about Rs 120 crore)

Alkem's Ankleshwar APIs facility receives three 483 observations from US FDA

These observations were issued following an inspection conducted by US FDA at the site from December 5-9, 2016

Lonza in talks with KKR to buy Capsugel

If the deal materialises, then experts believe that it would be worth more than $ 5 billion

Natco launches generic Tamiflu capsule in US

Tamiflu oral capsules had US sales of approximately $ 403 million for twelve months ending December 2015, according to IMS Health

Glenmark launches first generic version of Zetia in US

The company and its partner, Endo, will be entitled to 180 days of generic drug exclusivity for ezetimibe, which is used for the treatment of high cholesterol

Sun Pharma to partner with Israel's Moebius Medical for osteoarthritis drug

As per the licensing deal, Sun Pharma will have worldwide commercialisation & manufacturing rights for MM-II, a candidate for the treatment of pain in osteoarthritis